Han Soo Yoo Selected Research

Han Soo Yoo Research Topics

Disease

34	Parkinson Disease (Parkinson's Disease) 01/2024 - 01/2018
19	Dementia (Dementias) 01/2024 - 12/2018
19	Dyskinesias (Dyskinesia) 01/2023 - 01/2018
14	Cognitive Dysfunction 11/2023 - 01/2018
9	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 10/2005
5	Atrophy 01/2024 - 10/2018
5	Lewy Body Disease (Lewy Body Dementia) 01/2023 - 01/2020
5	Parkinsonian Disorders (Parkinsonism) 01/2023 - 07/2019
3	Disease Progression 11/2021 - 01/2019
3	Cerebral Cortical Thinning 01/2020 - 12/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2022
2	Body Weight (Weight, Body) 11/2021 - 01/2021
2	Synucleinopathies 01/2021 - 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Nervous System Diseases (Neurological Disorders) 11/2021
1	Sarcopenia 11/2021
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2021
1	Anosmia 01/2021
1	Hypokinesia (Bradykinesia) 01/2021
1	Genetic Risk Score 01/2021
1	Multiple System Atrophy 01/2020
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2019
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2018
1	Frontotemporal Dementia (Semantic Dementia) 01/2018
1	Diplopia (Double Vision) 05/2017
1	Ischemic Stroke 09/2013
1	Gastritis 05/2007
1	Neoplasms (Cancer) 05/2007
1	Dyspepsia (Indigestion) 05/2007
1	Colonic Neoplasms (Colon Cancer) 05/2007
1	Pheochromocytoma 10/2005
1	Ischemia 10/2005

Drug/Important Bio-Agent (IBA)

20	Levodopa (L Dopa)FDA LinkGeneric 01/2023 - 01/2018
16	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 01/2018
14	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 12/2022 - 01/2018
11	Amyloid (Amyloid Fibrils)IBA 01/2024 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2020
5	5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA 01/2021 - 10/2018
4	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2023 - 07/2019
3	CholesterolIBA 01/2024 - 11/2021
3	SynucleinsIBA 12/2023 - 01/2019
2	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2024 - 01/2021
2	Cholinergic Agents (Cholinergics)IBA 01/2024 - 01/2022
2	Neuroprotective AgentsIBA 01/2023 - 11/2021
2	Amyloid beta-PeptidesIBA 01/2021 - 10/2005
2	Cerebroside-Sulfatase (Arylsulfatase A)IBA 01/2020 - 01/2019
2	Uric Acid (Urate)IBA 01/2020 - 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	DihydropyridinesIBA 01/2023
1	alpha-SynucleinIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2021
1	Indicators and Reagents (Reagents)IBA 11/2021
1	Apolipoprotein E4IBA 10/2021
1	Donepezil (Aricept)FDA LinkGeneric 01/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	valrubicin (AD 32)FDA Link 01/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Dopamine Agonists (Dopamine Agonist)IBA 10/2018
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2007
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 05/2007
1	Peptides (Polypeptides)IBA 10/2005
1	TeaIBA 10/2005

Therapy/Procedure

1	Secondary Prevention 11/2021
1	Gastrectomy 01/2019
1	Aftercare (After-Treatment) 10/2018
1	Telescopes 05/2017
1	Thrombolytic Therapy 09/2013